Planoptik AG (P4O) Fair Value & Analysis
Technology · DE · Market cap €65.0M
Fair value as of: Jun 24, 2026
Analysis
Planoptik AG (P4O) currently trades at €9.60, while our model-based Fair Value estimate is €1.00 — implying the stock looks roughly 89.6% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Planoptik AG, together with its subsidiaries, manufactures and sells structured wafers in Germany and European Union. The company offers glass wafers; carrier chemical, thermal, laser, and mechanical release, as well as adapter carrier and tools; patterned packaging wafers with through holes, cavities, and channels; interposers; and structured and metallized glass substrates. It also provides microreactors; fluidic chips; phase separators; pumps; pressure sensors and holders; and nanoparticle, photochemistry, and flow chemistry starter sets, as well as medical devices. In addition, the company offers mechanical processing, patterning, wafer thinning, coating, wire sawing, and bonding, as well as metallization, redistribution layer, and 3D-integration; and pre-development, 3D-printing, vacuum casting, injection molding, and finishing services. It sells its products under the PLANOPTIK, ACT, and WAFER UNIVERSE brand names. The company serves the consumer electronics, automotive, aeros…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Planoptik AG (P4O) undervalued?
What is the fair value of P4O?
What is the quality score of P4O?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.